Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PSYLLIUM/DOCUSATE SALTS INCLUSION IN LAXATIVE MONOGRAPH URGED

This article was originally published in The Tan Sheet

Executive Summary

PSYLLIUM/DOCUSATE SALTS INCLUSION IN LAXATIVE MONOGRAPH URGED by Procter & Gamble in a Dec. 28 letter to FDA. P&G requested that the agency permit docusate sodium/psyllium and docusate calcium/psyllium as Category I (safe and effective) combinations under the OTC laxative products monograph. In a September 1993 notice of proposed rulemaking to amend the laxative tentative final monograph, FDA concluded that oral dosage forms of docusate sodium and docusate calcium and rectal enema dosage forms of docusate potassium are Category I as stool-softener laxative ingredients ("The Tan Sheet" Sept. 6, 1993, p. 5). P&G markets the psyllium-based laxative Metamucil.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS082333

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel